New York, NY USA

Our News on Newswise

Brain’s On-Off Thirst Switch Identified


Neurons that trigger our sense of thirst—and neurons that turn it off—have been identified by Columbia University Medical Center neuroscientists. The paper was published today in the online edition of Nature.
23-Jan-2015 3:00 PM EST

Bone Stem Cells Shown to Regenerate Bone and Cartilage in Adult Mice

A stem cell capable of regenerating both bone and cartilage has been identified in bone marrow of mice.
15-Jan-2015 3:00 PM EST

Biogen Idec and Columbia University Medical Center to Conduct Collaborative Genetics Research

Biogen Idec and Columbia University Medical Center have formed a $30 million strategic alliance to conduct genetics discovery research on the underlying causes of disease and to identify new treatment approaches.
8-Jan-2015 5:00 PM EST

Diverse Autism Mutations Lead to Different Disease Outcomes

People with autism have a wide range of symptoms, with no two people sharing the exact type and severity of behaviors. Now a large-scale analysis of hundreds of patients and nearly 1000 genes has started to uncover how diversity among traits can be...
18-Dec-2014 3:00 PM EST

Researchers Identify Non-Gluten Proteins as Targets of Immune Response to Wheat in Celiac Disease

Researchers at Columbia University Medical Center have found that, in addition to gluten, the immune systems of patients with celiac disease react to specific types of non-gluten protein in wheat.
15-Dec-2014 4:00 PM EST

Cause of Malaria Drug Resistance in Southeast Asia Identified

Malaria drug resistance in Southeast Asia is caused by a single mutated gene in the disease-causing parasite, a Columbia-led study has found.
11-Dec-2014 12:00 PM EST

Meniscus Regenerated with 3D-Printed Implant

Researchers have devised a way to replace the knee’s protective lining, called the meniscus, using a personalized 3D-printed implant, or scaffold, infused with human growth factors that prompt the body to regenerate the lining on its own. The...
10-Dec-2014 3:00 PM EST

Rare-Cancer Expert Richard Carvajal Appointed Director of Experimental Therapeutics


Richard D. Carvajal, MD, has been named director of the Experimental Therapeutics/Phase I program and melanoma service in medical oncology at NewYork-Presbyterian/Columbia University Medical Center, effective Nov. 1, 2014. Dr. Carvajal, a medical...
8-Dec-2014 2:00 PM EST

Our YouTube Videos